(NU/1433-47) Kargenera: The Provision of Business Consultancy to Assist Commercialisation of University Research

Newcastle University · Awarded

Buyer
Newcastle University
Status
Awarded
Country
United Kingdom
Region
England
Sector
Professional Services
Reference
FaT-ocds-h6vhtk-03a331
Published
2023-02-06
Deadline
2026-04-23

Tender summary

The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15. The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap